Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/23/2025

Teardrop Cells in Hematological Disorders

Diagnostic Considerations

  • MDS/myeloproliferative neoplasm (MPN) overlap syndromes can present with teardrop cells alongside other dysplastic features, according to the American Society of Hematology 1
  • The presence of schistocytes points toward microangiopathic hemolytic anemia (MAHA) rather than marrow pathology, as reported in Blood 2
  • Dysplastic features, such as pseudo-Pelger-Huët cells and hypogranulation, indicate myelodysplastic syndromes (MDS), as noted by the American College of Pathology 1
  • Cytopenias with dysplasia suggest MDS, while leukocytosis with monocytosis suggests chronic myelomonocytic leukemia (CMML), a type of MDS/MPN overlap syndrome, according to the National Comprehensive Cancer Network 1
  • Anemia with reticulocytosis suggests a hemolytic process, such as autoimmune hemolytic anemia (AIHA) or MAHA, as reported in Blood 2

Diagnostic Testing

  • Bone marrow examination, including aspiration and biopsy with reticulin stain, is essential when myelofibrosis or MDS is suspected, as recommended by the American Society of Clinical Oncology 1
  • Cytogenetic and molecular testing are necessary for MDS/MPN diagnosis, as chromosomal abnormalities occur in up to 80% of MDS patients, according to the International Society for Experimental Hematology 1